The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1349
October 18, 2010
View Complete Issue         Table of Contents 2019 
Mometasone/Formoterol (Dulera) for Asthma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Mometasone/Formoterol (Dulera) for Asthma
October 18, 2010 (Issue: 1349)
A combination of the corticosteroid mometasone furoate (Asmanex) and the long-acting beta2-agonist (LABA) formoterol (Foradil) has become available in a single metered-dose inhaler (Dulera – Schering) for treatment of asthma in patients ≥12...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Mometasone/Formoterol (Dulera) for Asthma
Article code: 1349c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.